Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) Short Interest Update

Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPFGet Free Report) was the target of a significant decrease in short interest in the month of September. As of September 15th, there was short interest totaling 33,200 shares, a decrease of 78.7% from the August 31st total of 156,100 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.

Towa Pharmaceutical Stock Performance

OTCMKTS:TWAPF opened at $25.33 on Wednesday. Towa Pharmaceutical has a 52 week low of $16.83 and a 52 week high of $25.33. The stock’s 50-day moving average price is $25.33 and its 200-day moving average price is $22.64.

About Towa Pharmaceutical

(Get Free Report)

Towa Pharmaceutical Co, Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products.

Featured Stories

Receive News & Ratings for Towa Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Towa Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.